135 related articles for article (PubMed ID: 10220638)
1. High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements?
Schulz O; Mitrovic V; Schönburg M; Thormann J
Am Heart J; 1999 May; 137(5):887-94. PubMed ID: 10220638
[TBL] [Abstract][Full Text] [Related]
2. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
[TBL] [Abstract][Full Text] [Related]
3. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
4. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
Berti S; Palmieri C; Ravani M; Bonini R; Iascone MR; Clerico A; Manfredi C; Iervasi G; Ferrazzi P; Biagini A
Cardiovasc Drugs Ther; 1996 Mar; 10(1):81-7. PubMed ID: 8723174
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
6. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
[TBL] [Abstract][Full Text] [Related]
7. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
Sigurdsson A; Amtorp O; Gundersen T; Nilsson B; Remes J; Swedberg K
Br Heart J; 1994 Nov; 72(5):422-7. PubMed ID: 7818958
[TBL] [Abstract][Full Text] [Related]
8. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
[TBL] [Abstract][Full Text] [Related]
9. Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Hisanaga T; Maeda K; Ohnishi M; Mabuchi N; Sawaki M; Hayashi M; Fujii M; Kinoshita M
J Am Coll Cardiol; 1999 Feb; 33(2):530-7. PubMed ID: 9973035
[TBL] [Abstract][Full Text] [Related]
10. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.
Smith NA; Kates RE; Lebsack C; Ruder MA; Mead RH; Bekele T; Okerholm RA; Rubin GM; Winkle RA
Am Heart J; 1991 Sep; 122(3 Pt 1):755-63. PubMed ID: 1831585
[TBL] [Abstract][Full Text] [Related]
12. ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada.
Parker AB; Azevedo ER; Baird MG; Smith SJ; Arnold JM; Humen DP; Moe GW; Parker JO; Butt RW; Parker JD
Am Heart J; 1999 Nov; 138(5 Pt 1):843-8. PubMed ID: 10539814
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
14. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
Berglund H; Nyquist O; Beermann B; Jensen-Urstad M; Theodorsson E
Br Heart J; 1994 Dec; 72(6):521-7. PubMed ID: 7857733
[TBL] [Abstract][Full Text] [Related]
15. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
Rousseau MF; Gurné O; Duprez D; Van Mieghem W; Robert A; Ahn S; Galanti L; Ketelslegers JM;
J Am Coll Cardiol; 2002 Nov; 40(9):1596-601. PubMed ID: 12427411
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of prolonged enoximone infusion (7 days) in patients with severe chronic heart failure.
Gibelin P; Dadoun-Dybal M; Candito M; Robillon JF; Morand P
Cardiovasc Drugs Ther; 1993 Jun; 7(3):333-6. PubMed ID: 8364003
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
18. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
Leier CV; Lima JJ; Meiler SE; Unverferth DV
Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease.
Mitrovic V; Thormann J; Neuzner J; Bahawar H; Volz M; Dieterich HA; Schlepper M
Am Heart J; 1989 Jan; 117(1):106-11. PubMed ID: 2563185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
